Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM

**Semantic type:** Cell|Immunologic Factor|Pharmacologic Substance

**Definition:** A vaccine consisting of irradiated allogeneic breast cancer cells, derived from the breast cancer cell line SV-BR-1 that are transfected with the immunostimulant granulocyte-macrophage colony-stimulating factor (GM-CSF; CSF2) gene, with potential immunostimulating and antineoplastic activities. Upon intradermal administration of the allogeneic GM-CSF-secreting breast cancer vaccine SV-BR-1-GM, the genetically-modified cells secrete GM-CSF. This potentiates a tumor-specific cytotoxic T-lymphocyte (CTL) immune response against breast cancer cells.

**Synonyms:** - Breast Cancer Vaccine SV-BR-1-GM - Bria-IMT - GM-CSF Gene-transfected Breast Cancer Vaccine SV-BR-1-GM - SV-BR-1 Breast Cancer Cell Line Vaccine - SV-BR-1-GM - SV-BR-1-GM Vaccine